Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Bioventures 2014, L.p. Mpm

10% Owner at Werewolf Therapeutics, Inc. (HOWL)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $241K

Reported trades

Filed Stock Type Shares Price Value Since
Nov 12SEC HOWLWerewolf Therapeutics, Inc. Sell Plan 68,4805,836,240 held (−1%) $1.11 $76K -11.7%
Nov 12SEC HOWLWerewolf Therapeutics, Inc. Sell Plan 48,5705,787,670 held (−1%) $1.18 $57K -16.9%
Nov 12SEC HOWLWerewolf Therapeutics, Inc. Sell Plan 55,8105,731,860 held (−1%) $1.14 $64K -14.0%
Nov 12SEC HOWLWerewolf Therapeutics, Inc. Sell Plan 40,6695,691,191 held (−1%) $1.09 $44K -10.1%
  • Sell

    10% Owner Bioventures 2014, L.p. Mpm sold $76K of HOWL at $1.11 — pre-scheduled 10b5-1 plan sale.

  • Sell

    10% Owner Bioventures 2014, L.p. Mpm sold $57K of HOWL at $1.18 — pre-scheduled 10b5-1 plan sale.

  • Sell

    10% Owner Bioventures 2014, L.p. Mpm sold $64K of HOWL at $1.14 — pre-scheduled 10b5-1 plan sale.

  • Sell

    10% Owner Bioventures 2014, L.p. Mpm sold $44K of HOWL at $1.09 — pre-scheduled 10b5-1 plan sale.